FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

35371211000001105: Iraksin 20microgram tablets (Morningside Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-May 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
106941601000001110 Iraksin 20microgram tablets (Morningside Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106941701000001117 Iraksin 20microgram tablets (Morningside Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Iraksin 20microgram tablets (Morningside Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Iraksin 20microgram tablets (Morningside Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Iraksin 20microgram tablets (Morningside Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Iraksin 20microgram tablets (Morningside Healthcare Ltd) Is a Product containing precisely liothyronine sodium 20 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Iraksin 20microgram tablets (Morningside Healthcare Ltd) Has active ingredient Liothyronine sodium false Inferred relationship Existential restriction modifier 1
Iraksin 20microgram tablets (Morningside Healthcare Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Iraksin 20microgram tablets (Morningside Healthcare Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Iraksin 20microgram tablets (Morningside Healthcare Ltd) Has basis of strength substance Liothyronine sodium true Inferred relationship Existential restriction modifier 1
Iraksin 20microgram tablets (Morningside Healthcare Ltd) Has presentation strength numerator value 20 false Inferred relationship Existential restriction modifier 1
Iraksin 20microgram tablets (Morningside Healthcare Ltd) Has presentation strength numerator unit microgram true Inferred relationship Existential restriction modifier 1
Iraksin 20microgram tablets (Morningside Healthcare Ltd) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Iraksin 20microgram tablets (Morningside Healthcare Ltd) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Iraksin 20microgram tablets (Morningside Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Iraksin 20microgram tablets (Morningside Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Iraksin 20microgram tablets (Morningside Healthcare Ltd) Has specific active ingredient Liothyronine sodium true Inferred relationship Existential restriction modifier
Iraksin 20microgram tablets (Morningside Healthcare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Iraksin 20microgram tablets (Morningside Healthcare Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Iraksin 20microgram tablets (Morningside Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Iraksin 20microgram tablets (Morningside Healthcare Ltd) Is a Iraksin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Iraksin 20microgram tablets (Morningside Healthcare Ltd) 28 tablet 2 x 14 tablets Has AMP True Iraksin 20microgram tablets (Morningside Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start